Although the postoperative immunohistochemistry showed (Figures 3, 4) the loss of SMARCB1/INI-1 expression and the negative expression of OCT4, considering the location of the tumor and the patient’s age, the patient still received adjuvant chemotherapy for testicular seminoma after surgery. Here, SMARCB1 is linked to testicular seminoma.